Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Influenza vaccination of children and infection rates in the community.

Small PA Jr, Morris JG Jr.

JAMA. 2010 Jun 16;303(23):2355-6; author reply 2356. doi: 10.1001/jama.2010.779. No abstract available.

PMID:
20551404
2.

Recent changes in influenza epidemiology and vaccination recommendations.

Zimmerman RK.

J Fam Pract. 2005 Jan;54(1 Suppl):S1-8. Review.

PMID:
15623391
3.

[Importance of influenza in the child. Intranasal influenza vaccine: another systematic vaccination?].

Moraga Llop FA, Campins Martí M.

An Esp Pediatr. 2000 Oct;53(4):299-304. Spanish. No abstract available.

PMID:
11523509
4.

Influenza vaccine for children.

Neuzil KM.

Clin Infect Dis. 2004 Mar 1;38(5):689-91. Epub 2004 Feb 17. No abstract available.

PMID:
14986253
5.

Choosing between live attenuated and trivalent inactivated influenza vaccines for healthy children.

Tingle MT, Hayney MS.

J Am Pharm Assoc (2003). 2011 Nov-Dec;51(6):776-7. doi: 10.1331/JAPhA.2011.11547. No abstract available.

PMID:
22068202
6.

Intradermal vaccination against influenza.

Manian FA.

N Engl J Med. 2005 Mar 10;352(10):1044-6; author reply 1044-6. No abstract available.

PMID:
15761999
7.

Optimizing protection against influenza in children eligible for the vaccine for children program.

Hull HF, O'Connor H.

Pediatr Infect Dis J. 2010 Oct;29(10):910-4. doi: 10.1097/INF.0b013e3181e05579.

PMID:
20431426
8.

Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.

Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, Zimmerman N, Glezen WP.

Pediatrics. 2007 Sep;120(3):e553-64. Epub 2007 Aug 13.

PMID:
17698577
9.

[Vaccine prophylaxis of influenza].

Fridman EA, Bichurina MA.

Tr Inst Im Pastera. 1992;67:45-64. Review. Russian. No abstract available.

PMID:
8539767
10.

Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) cluster randomized trial: Pilot results from a household surveillance study to assess direct and indirect protection from influenza vaccination.

Kwong JC, Pereira JA, Quach S, Pellizzari R, Dusome E, Russell ML, Hamid JS, Feinberg Y, Winter AL, Gubbay JB, Sirtonski B, Moher D, Sider D, Finkelstein M, Loeb M; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Program Delivery and Evaluation Group.

Vaccine. 2015 Sep 11;33(38):4910-5. doi: 10.1016/j.vaccine.2015.07.044. Epub 2015 Jul 29.

11.

New recommendation for childhood influenza vaccine.

Donlin J.

NCSL Legisbrief. 2004 Aug-Sep;12(34):1-2. No abstract available.

PMID:
15344289
12.

Influenza vaccine 2005-2006.

[No authors listed]

Med Lett Drugs Ther. 2005 Oct 24;47(1220):85-7. No abstract available.

PMID:
16264371
13.

Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season.

Grohskopf LA, Sokolow LZ, Olsen SJ, Bresee JS, Broder KR, Karron RA.

MMWR Morb Mortal Wkly Rep. 2015 Aug 7;64(30):818-25.

14.

Inactivated influenza virus vaccines in children.

Ruben FL.

Clin Infect Dis. 2004 Mar 1;38(5):678-88. Epub 2004 Feb 17. Review.

PMID:
14986252
15.

Update on influenza A (H1N1) 2009 monovalent vaccines.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Oct 9;58(39):1100-1.

16.

Complexities in assessing the effectiveness of inactivated influenza vaccines.

Kelly H, Steffens I.

Euro Surveill. 2013 Feb 14;18(7):1. No abstract available.

17.

Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren.

Khan AS, Polezhaev F, Vasiljeva R, Drinevsky V, Buffington J, Gary H, Sominina A, Keitel W, Regnery H, Lonskaya NL, Doroshenko E, Gavrilov A, Ivakhov I, Arden N, Schonberger LB, Couch R, Kendal A, Cox N.

J Infect Dis. 1996 Feb;173(2):453-6.

PMID:
8568310
18.
19.

A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older.

Forrest BD, Steele AD, Hiemstra L, Rappaport R, Ambrose CS, Gruber WC.

Vaccine. 2011 May 9;29(20):3633-9. doi: 10.1016/j.vaccine.2011.03.029. Epub 2011 Apr 5.

PMID:
21440036
20.

Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.

Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B; CAIV-T Asthma Study Group.

Pediatr Infect Dis J. 2006 Oct;25(10):860-9.

PMID:
17006278

Supplemental Content

Support Center